alfapump system

DEVICE3 trials

Sponsors

Sequana Medical N.V.

Conditions

AscitesCirrhosisCirrhosis, LiverMalignant AscitesRefractory Ascites

Phase 2

Effects of Treatment of Ascites by the ALFApump System on Renal and Circulatory Function

Sequana Medical N.V.Cirrhosis, Liver, Refractory Ascites

Start: 2011-09-30End: 2016-12-31Target: 12Updated: 2016-08-11

Unknown Phase

A (M)Ulti-center, Prospective, (O)Pen Label, Uncontrolled Feasibility (S)Tudy to Assess the Safety and Effectiveness of an Automatic Low Flow (A)Scites (Alfa) Pump (I)n Patients With (C)Irrhosis and Refractory or Recurrent Ascites

CompletedNCT02400164

Sequana Medical N.V.Ascites, Cirrhosis

Start: 2015-03-31End: 2018-03-31Updated: 2018-04-06

Malignant Ascites Alfapump® Study

WithdrawnNCT04076566

Sequana Medical N.V.Malignant Ascites

Start: 2020-05-31End: 2022-03-31Updated: 2020-08-10